Stay updated on Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe history shows a new revision entry (v3.5.0) added and an older revision (v3.4.3) removed.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.4.3 was added to the history log and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.4.2 was added. The notice about lapse in government funding and the prior Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check74 days agoChange DetectedSite-wide updates include a government funding notice and a revision upgrade from v3.4.0 to v3.4.1. These changes do not affect the study record content or history data.SummaryDifference0.4%

- Check81 days agoChange DetectedThe history page now shows a glossary and uses green highlights for additions and red highlights for deletions, with color-coded change indicators and a revision label (v3.4.0). The previous No FEAR Act data label and revision (v3.3.4) were removed.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.